Vector-Borne and Zoonotic Diseases
ISSN 1530-3667 · Mary Ann Liebert, Inc. · United States · active 2001–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Vector-Borne and Zoonotic Diseases a predatory journal?
Our screening does not flag Vector-Borne and Zoonotic Diseases. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Vector-Borne and Zoonotic Diseases indexed in Scopus or Web of Science?
Per our venue index, Vector-Borne and Zoonotic Diseases appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Vector-Borne and Zoonotic Diseases's impact?
Papers in Vector-Borne and Zoonotic Diseases are cited about 1.5 times each within two years of publication, and Scimago places it in Q2, with an h-index of 103. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Vector-Borne and Zoonotic Diseases open access?
We hold no reliable open-access classification for Vector-Borne and Zoonotic Diseases. Check the journal's own site for its access model and any article processing charge.
Similar venues
- MMWR Morbidity and Mortality Weekly ReportQ1 · Centers for Disease Control and Prevention
- Clinical Microbiology ReviewsQ1 · American Society for Microbiology
- The Lancet Infectious DiseasesQ1 · Elsevier BV
- Biotechnology AdvancesQ1 · Elsevier BV
- Current Opinion in Chemical EngineeringQ1 · Elsevier BV
- EurosurveillanceQ1 · European Centre for Disease Prevention and Control